Detalhe da pesquisa
1.
Analysis of the First Round of Public Comments for the National Coverage Determination for Monoclonal Antibodies in the Treatment of Alzheimer's Disease.
J Aging Soc Policy
; : 1-20, 2023 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486161